Skip to main content

Table 1 Studies included in the pooled DIAB-CORE sample (45–74 years)

From: Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation

Study

Region

Study period

N (%)

Age (years)

Hypertension

Dyslipidemia

    

mean (SD)

N (%)

N (%)

SHIP a

North-east

1997–2001

251 (19.5)

62.8 (7.5)

215 (85.7)

143 (57.0)

 

Germany

     
 

(West Pomerania)

     

DHS b

West Germany

2003–2004

87 (6.8)

64.1 (8.0)

73 (83.9)

-

 

(Dortmund)

     

CARLA c

East Germany

2002–2006

174 (13.5)

63.5 (7.3)

155 (89.6)

84 (48.6)

 

(Halle)

     

HNR d

West Germany (Bochum, Essen, Mülheim an der Ruhr)

2000–2003

350 (27.2)

63.0 (7.2)

263 (78.5)

174 (52.1)

KORA e

South Germany

1999–2001

146 (11.3)

63.3 (6.7)

114 (78.6)

80 (55.9)

 

(Augsburg region)

     

GNHIES98 f

Nationwide

1997–1999

279 (21.7)

62.7 (6.8)

228 (81.7)

155 (59.6)

Total

 

1997–2006

1287

63.1 (7.2)

1048 (82.5)

636 (54.8)

  1. aSHIP: Study of Health in Pomerania; bDHS: Dortmund Health Study; cCARLA: Cardiovascular Disease, Living and Ageing in Halle; d HNR: Heinz Nixdorf-Recall; eKORA (Survey S4): Cooperative Health Research in the Region of Augsburg; fGNHIES98: German National Health Interview and Examination Survey 1998.
  2. BP > = 140/90 mmHg or using anti-hypertensive medication.
  3. TC/HDL > = 5 or using lipid-lowering medication.